Literature DB >> 32454234

COVID-19 pandemic and vascular surgery unit.

Sora Yasri1, Viroj Wiwanitkit2.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32454234      PMCID: PMC7245303          DOI: 10.1016/j.jvs.2020.05.025

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


× No keyword cloud information.
We found the publication “Early experience in the COVID-19 pandemic from a vascular surgery unit in a Singapore tertiary hospital” very interesting. Tan et al stated, “Surgical services form an essential component of the health care system, but as surgeons, we need to be versatile and be able to respond to the ever evolving pandemic situation.” The risk of COVID-19 transmission to the surgeon during surgery is possible. The preventive measures explained by Tan et al are useful in other settings. In addition to general preventive measures, there should be a good surgery management system to postpone unnecessary surgery. In Indochina, almost all vascular surgeries are not done during the COVID-19 outbreak. In case the vascular surgical procedure is required, presurgery testing for COVID-19 is recommended, and the practitioner should follow standard universal precautions for all patients in all phases of surgery, before, during, and after operation.
  3 in total

1.  Carpal Fracture and COVID-19 Infection: Observation from Thailand.

Authors:  Beuy Joob; Viroj Wiwanitkit
Journal:  Indian J Orthop       Date:  2020-04-21       Impact factor: 1.251

2.  Early experience in the COVID-19 pandemic from a vascular surgery unit in a Singapore tertiary hospital.

Authors:  Glenn Wei Leong Tan; Sadhana Chandrasekar; Zhiwen Joseph Lo; Qiantai Hong; Enming Yong; Pravin Lingam; Li Zhang; Lawrence Han Hwee Quek; Uei Pua
Journal:  J Vasc Surg       Date:  2020-04-17       Impact factor: 4.268

3.  Testing recommendation for COVID-19 (SARS-CoV-2) in patients planned for surgery - continuing the service and 'suppressing' the pandemic.

Authors:  M A Al-Muharraqi
Journal:  Br J Oral Maxillofac Surg       Date:  2020-04-13       Impact factor: 1.651

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.